Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

IDH1 Antikörper (AA 281-414)

Dieses Anti-IDH1-Antikörper ist ein Maus Monoklonal-Antikörper zur Detektion von IDH1 in IHC und StM. Geeignet für Human.
Produktnummer ABIN6939688

Kurzübersicht für IDH1 Antikörper (AA 281-414) (ABIN6939688)

Target

Alle IDH1 Antikörper anzeigen
IDH1 (Isocitrate Dehydrogenase 1 (NADP+), Soluble (IDH1))

Reaktivität

  • 133
  • 69
  • 48
  • 8
  • 7
  • 7
  • 5
  • 5
  • 5
  • 4
  • 4
  • 4
  • 3
  • 2
  • 2
  • 1
  • 1
Human

Wirt

  • 98
  • 56
  • 3
  • 1
Maus

Klonalität

  • 89
  • 69
Monoklonal

Konjugat

  • 100
  • 11
  • 10
  • 4
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Dieser IDH1 Antikörper ist unkonjugiert

Applikation

  • 112
  • 62
  • 36
  • 34
  • 34
  • 30
  • 28
  • 15
  • 13
  • 9
  • 5
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
Immunohistochemistry (IHC), Staining Methods (StM)

Klon

IDH1-1152
  • Bindungsspezifität

    • 15
    • 14
    • 12
    • 10
    • 6
    • 4
    • 4
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 281-414

    Spezifität

    It recognizes a 45 kDa protein, which is identified as isocitrate dehydrogenase (IDH1). It belongs to the isocitrate and isopropylmalate dehydrogenases family. IDH1 catalyzes the third step of the citric acid cycle, which involves the oxidative decarboxylation of isocitrate, forming -ketoglutarate. During this process, either NADH or NADPH is produced along with CO2. Recently, an inactivating mutation of IDH1 has been implicated in glioblastoma. IDH1 appears to function as a tumor suppressor that, when mutationally inactivated, contributes to tumorigenesis in part through induction of the HIF-1 pathway.

    Aufreinigung

    Purified by Protein A/G

    Immunogen

    Recombinant fragment of human IDH1 protein (around aa 281-414) (exact sequence is proprietary)

    Isotyp

    IgG1 kappa
  • Applikationshinweise

    Positive Control: HepG2, HeLa, HT29 or MCF7 cells. Breast, Colon or Prostate Carcinoma.

    Known Application: Immunohistochemistry (Formalin-fixed) (0.5-1 μg/mL for 30 minutes at RT)(Staining of formalin-fixed tissues requires boiling tissue sections in 10 mM Citrate buffer, pH 6.0, for 10-20 min followed by cooling at RT for 20 minutes)Optimal dilution for a specific application should be determined.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Konzentration

    200 μg/mL

    Buffer

    10 mM PBS with 0.05 % BSA & 0.05 % azide.

    Konservierungsmittel

    Sodium azide

    Vorsichtsmaßnahmen

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Lagerung

    4 °C,-80 °C

    Informationen zur Lagerung

    Antibody with azide - store at 2 to 8°C. Antibody without azide - store at -20 to -80°C. Antibody is stable for 24 months. Non-hazardous. No MSDS required.

    Haltbarkeit

    24 months
  • Target

    IDH1 (Isocitrate Dehydrogenase 1 (NADP+), Soluble (IDH1))

    Andere Bezeichnung

    IDH1

    Molekulargewicht

    45-47kDa

    Gen-ID

    3417

    UniProt

    O75874

    Pathways

    Warburg Effekt
Sie sind hier:
Chat with us!